Cargando…
Features of Effective T Cell-Inducing Vaccines against Chronic Viral Infections
For many years, the focus of prophylactic vaccines was to elicit neutralizing antibodies, but it has become increasingly evident that T cell-mediated immunity plays a central role in controlling persistent viral infections such as with human immunodeficiency virus, cytomegalovirus, and hepatitis C v...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5820320/ https://www.ncbi.nlm.nih.gov/pubmed/29503649 http://dx.doi.org/10.3389/fimmu.2018.00276 |
_version_ | 1783301340826435584 |
---|---|
author | Panagioti, Eleni Klenerman, Paul Lee, Lian N. van der Burg, Sjoerd H. Arens, Ramon |
author_facet | Panagioti, Eleni Klenerman, Paul Lee, Lian N. van der Burg, Sjoerd H. Arens, Ramon |
author_sort | Panagioti, Eleni |
collection | PubMed |
description | For many years, the focus of prophylactic vaccines was to elicit neutralizing antibodies, but it has become increasingly evident that T cell-mediated immunity plays a central role in controlling persistent viral infections such as with human immunodeficiency virus, cytomegalovirus, and hepatitis C virus. Currently, various promising prophylactic vaccines, capable of inducing substantial vaccine-specific T cell responses, are investigated in preclinical and clinical studies. There is compelling evidence that protection by T cells is related to the magnitude and breadth of the T cell response, the type and homing properties of the memory T cell subsets, and their cytokine polyfunctionality and metabolic fitness. In this review, we evaluated these key factors that determine the qualitative and quantitative properties of CD4(+) and CD8(+) T cell responses in the context of chronic viral disease and prophylactic vaccine development. Elucidation of the mechanisms underlying T cell-mediated protection against chronic viral pathogens will facilitate the development of more potent, durable and safe prophylactic T cell-based vaccines. |
format | Online Article Text |
id | pubmed-5820320 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-58203202018-03-02 Features of Effective T Cell-Inducing Vaccines against Chronic Viral Infections Panagioti, Eleni Klenerman, Paul Lee, Lian N. van der Burg, Sjoerd H. Arens, Ramon Front Immunol Immunology For many years, the focus of prophylactic vaccines was to elicit neutralizing antibodies, but it has become increasingly evident that T cell-mediated immunity plays a central role in controlling persistent viral infections such as with human immunodeficiency virus, cytomegalovirus, and hepatitis C virus. Currently, various promising prophylactic vaccines, capable of inducing substantial vaccine-specific T cell responses, are investigated in preclinical and clinical studies. There is compelling evidence that protection by T cells is related to the magnitude and breadth of the T cell response, the type and homing properties of the memory T cell subsets, and their cytokine polyfunctionality and metabolic fitness. In this review, we evaluated these key factors that determine the qualitative and quantitative properties of CD4(+) and CD8(+) T cell responses in the context of chronic viral disease and prophylactic vaccine development. Elucidation of the mechanisms underlying T cell-mediated protection against chronic viral pathogens will facilitate the development of more potent, durable and safe prophylactic T cell-based vaccines. Frontiers Media S.A. 2018-02-16 /pmc/articles/PMC5820320/ /pubmed/29503649 http://dx.doi.org/10.3389/fimmu.2018.00276 Text en Copyright © 2018 Panagioti, Klenerman, Lee, van der Burg and Arens. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Panagioti, Eleni Klenerman, Paul Lee, Lian N. van der Burg, Sjoerd H. Arens, Ramon Features of Effective T Cell-Inducing Vaccines against Chronic Viral Infections |
title | Features of Effective T Cell-Inducing Vaccines against Chronic Viral Infections |
title_full | Features of Effective T Cell-Inducing Vaccines against Chronic Viral Infections |
title_fullStr | Features of Effective T Cell-Inducing Vaccines against Chronic Viral Infections |
title_full_unstemmed | Features of Effective T Cell-Inducing Vaccines against Chronic Viral Infections |
title_short | Features of Effective T Cell-Inducing Vaccines against Chronic Viral Infections |
title_sort | features of effective t cell-inducing vaccines against chronic viral infections |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5820320/ https://www.ncbi.nlm.nih.gov/pubmed/29503649 http://dx.doi.org/10.3389/fimmu.2018.00276 |
work_keys_str_mv | AT panagiotieleni featuresofeffectivetcellinducingvaccinesagainstchronicviralinfections AT klenermanpaul featuresofeffectivetcellinducingvaccinesagainstchronicviralinfections AT leeliann featuresofeffectivetcellinducingvaccinesagainstchronicviralinfections AT vanderburgsjoerdh featuresofeffectivetcellinducingvaccinesagainstchronicviralinfections AT arensramon featuresofeffectivetcellinducingvaccinesagainstchronicviralinfections |